| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 23, 2007
Accepted on September 26, 2007
From the Department of Social Medicine (A.F., R.H., G.D.S., D.A.L.), University of Bristol, UK; the Department of Vascular Biochemistry (N.S.), University of Glasgow, Scotland; the Department of Epidemiology & Population Health (S.E.), London School of Hygiene & Tropical Medicine, UK; and MRC Centre for Causal Analyses in Translational Epidemiology (G.D.S., D.A.L.), University of Bristol, UK.
* To whom correspondence should be addressed. E-mail: Abigail.Fraser{at}bristol.ac.uk.
Objective—
-glutamyltransferase (GGT) is a marker of alcohol intake but may also reflect oxidative stress and nonalcoholic fatty liver disease. Alanine aminotransferase (ALT) is the enzyme most closely associated with liver fat content.
Methods and Results—Associations of GGT and ALT with incident CHD, stroke, and a combined outcome of CHD or stroke were examined in the British Womens Heart and Health study (n=2961), and a meta-analysis of population based studies examining these associations was performed. In pooled analyses of fully adjusted results of 10 prospective studies, a change of 1 U/L of GGT was associated with a HR=1.20 (95% CI: 1.02, 1.40) for CHD; a HR=1.54 (95% CI: 1.20, 2.00) for stroke; and HR=1.34 (95% CI: 1.22, 1.48) for CHD or stroke. Heterogeneity was substantially decreased when 2 studies in Asian populations were excluded. In a subgroup of nondrinkers results were similar to the main analysis. Meta analyses of the only 2 studies that examined the association of ALT with incident cardiovascular events found a HR=1.18, 95% CI: 0.99, 1.41) for CHD and a HR=1.10 (95% CI: 0.89, 1.36) for CHD or stroke (combined).
Conclusion—GGT is associated with incident vascular events independently of alcohol intake. The mechanisms underlying this association remain unclear and require future study.
-glutamyltransferase
cardiocascular diseases
meta-analysis
This article has been cited by other articles:
![]() |
K. K. Sato, T. Hayashi, Y. Nakamura, N. Harita, T. Yoneda, G. Endo, and H. Kambe Liver Enzymes Compared With Alcohol Consumption in Predicting the Risk of Type 2 Diabetes: The Kansai Healthcare Study Diabetes Care, June 1, 2008; 31(6): 1230 - 1236. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Fraser, N. Sattar, S. Ebrahim, and D.A. Lawlor Is Serum-Glutamylatransferase a Biomarker of Xenobiotics Which Are Conjugated by Glutathione? Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): e29 - e29. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |